• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TGR
Click for more information
0.26% $3.89

TASSAL GROUP LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
TGR
Ann: Change of Director's Interest Notice 		06/09/19 0 1
06/09/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1 
TGR
Ann: 2019 Interim Dividend - DRP- Issue Price 		28/03/19 0 109
28/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  109 
TGR
TGR reached $5 twice before, fell back both times. What’s different this time? 		27/03/19 17 3.9K
27/03/19 Last post  Sqwark77 Comments Created with Sketch.  17  Views Created with Sketch.  3.9K 
TGR
Ann: Ceasing to be a substantial holder 		22/03/19 0 164
22/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  164 
TGR
Ann: Change in substantial holding 		22/03/19 1 260
22/03/19 Last post  Spitfire84 Comments Created with Sketch.  1  Views Created with Sketch.  260 
TGR
Ann: Becoming a substantial holder 		19/03/19 0 9.1K
19/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  9.1K 
TGR
Ann: Change of Director's Interest Notice 		07/03/19 7 3.5K
07/03/19 Last post  GrazerAu Comments Created with Sketch.  7  Views Created with Sketch.  3.5K 
TGR
Ann: Tassal - Exectuive Director share trading update 		21/02/19 5 1.5K
21/02/19 Last post  Nick_btw1 Comments Created with Sketch.  5  Views Created with Sketch.  1.5K 

See All Discussions arrow Created with Sketch.

Top Stories

Scientific conference spotlights PYC's work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.